Kuala Lumpur, Nov 1: DC Healthcare Holdings Berhad, a leading provider of aesthetic medical services, has unveiled ‘newB,’ an innovative skincare line developed by its subsidiary, Ten Doctors Sdn Bhd (10DRS).
The new product range consists of two categories: newB Premium Ageless and newB Premium Hydration, designed to set new standards in skincare effectiveness.
The newB Premium Ageless range is formulated with the revolutionary ingredient DiamondC60™, delivering potent anti-ageing benefits.
This groundbreaking ingredient, sourced from Japan, exhibits superior anti-oxidative performance compared to traditional anti-ageing components like Vitamin C.
On the other hand, the newB Premium Hydration collection is powered by the 7HA Boost Complex, incorporating seven distinct molecular sizes of hyaluronic acid and FUCOGEL® to ensure lasting hydration for healthy, soft, and plump skin.
Dr Chong Tze Sheng, Managing Director of DC Healthcare, expressed, “The launch of newB is a strategic move in diversifying our healthcare portfolio.
Our skincare products are developed with scientific precision, catering to the evolving skincare needs of our clientele.
These new product lines not only contribute to our revenue streams but also enhance our reputation as a comprehensive healthcare provider. We are particularly encouraged by the commercial applications of DiamondC60™, an ingredient that we believe will set new industry standards.”
With projections indicating an 18.8 per cent CAGR in the Malaysian aesthetic medicine market from 2021 to 2027, the launch of newB aligns with DC Healthcare’s dedication to innovation and excellence.
The skincare products are available for purchase through various online platforms, including Shopee, Lazada, TikTok shop, and Watsons Malaysia Online Store.
DC Healthcare remains committed to its core business, focusing on aesthetic services and innovative healthcare solutions, including newB.
The company’s plans involve expanding existing clinics, investing in cutting-edge technology, and strengthening its team of medical professionals to seize growth opportunities within the aesthetic medicine market.
As of last month, DC Healthcare’s share price stands at 0.52 sen per share, reflecting a market capitalization of RM518.1 million.
For interview requests and press releases, please contact us at editor@dailystraits.com. For advertising inquiries, please email sales@dailystraits.com. Thank you.